Scarica l'app Stockscreener
5.38
0.94%
0.05
Dopo l'orario di chiusura:
4.34
-1.04
-19.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.33
Aprire:
$5.28
Volume 24 ore:
191.57K
Relative Volume:
0.31
Capitalizzazione di mercato:
$143.21M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-3.8429
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
-2.71%
1M Prestazione:
-13.92%
6M Prestazione:
-40.35%
1 anno Prestazione:
-49.67%
Intervallo 1D:
$5.1871
$5.43
Intervallo di 1 settimana:
$5.02
$5.51
Portata 52W:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.38 | 142.39M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-08 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
AVITA Medical, Inc. Provides preliminary Revenue Guidance for the Third Quarter Ended September 30, 2025 - MarketScreener
Avita Medical Appoints Interim CEO, Issues Q3 Revenue Guidance; Shares Tumble 20% - MarketScreener
AVITA Medical Announces CEO Transition - The Manila Times
$17M Q3 2025 Revenue — AVITA Medical Names Cary Vance Interim CEO; Jan Stern Reed Lead Director - Stock Titan
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. - GlobeNewswire
Using economic indicators to assess AVITA Medical Inc. potentialQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Why AVITA Medical Inc. stock remains resilient2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com
Is AVITA Medical Inc. reversing from oversold territoryWatch List & Free Verified High Yield Trade Plans - newser.com
How to manage a losing position in AVITA Medical Inc.Portfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Is AVITA Medical Inc. stock a top pick in earnings season2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
How risky is AVITA Medical Inc. stock nowTake Profit & Fast Momentum Entry Tips - newser.com
Analyzing drawdowns of AVITA Medical Inc. with statistical toolsTrade Signal Summary & Entry Point Strategy Guides - newser.com
Is it too late to sell AVITA Medical Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
Will AVITA Medical Inc. stock recover faster than peersWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
Real time social sentiment graph for AVITA Medical Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Is AVITA Medical Inc. stock a buy for dividend growthJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc.RCEL - cnhinews.com
How AVITA Medical Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
What technical models suggest about AVITA Medical Inc.’s comeback - newser.com
Applying sector rotation models to AVITA Medical Inc.2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
AVITA Medical Inc. stock trend forecastSell Signal & High Win Rate Trade Tips - newser.com
Smart tools for monitoring AVITA Medical Inc.’s price actionJuly 2025 Update & Technical Pattern Alert System - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA - GlobeNewswire
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders - GlobeNewswire Inc.
How to interpret RSI for AVITA Medical Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Custom strategy builders for tracking AVITA Medical Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What drives AVITA Medical Inc stock priceStraddle and Strangle Trades & Bull Bear Market Updates - earlytimes.in
Understanding AVITA Medical Inc.’s price movementJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
RCEL: Kirby McInerney LLP Continues Securities Investigation on Behalf of AVITA Medical, Inc. Investors - ACCESS Newswire
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Upcoming Events - FinancialContent
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Combining machine learning predictions for AVITA Medical Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com
Applying Wyckoff theory to AVITA Medical Inc. stock2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avita Medical Inc Azioni (RCEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):